Sensor Technology for Opening New Pathways in Diagnosis and Therapeutics of Breast, Lung, Colorectal and Prostate Cancer

Abstract

This study analyzes the interaction between sensor research and technology and different types of cancer (breast, lung, colorectal, and prostate) with the goal of detecting new directions for improving diagnosis and therapeutics in medicine. This study develops an approach to computational scientometrics based on data from the Web of Science from the 1991 to 2021 period. The results of this analysis show the vital role of biosensors and electrochemical biosensors applied in breast cancer, lung cancer, and prostate cancer research. Instead, scientific research of optical sensors is developing main technological trajectories in breast, prostate, and colorectal cancer for improving diagnostics. Finally, oxygen sensor research has a main technological development in breast and lung cancer for new applications in breath analysis directed to treatment processes. Preliminary results presented here clearly illustrate the evolutionary paths of sensor research and technologies that have great potential for developing incremental and radical innovations in cancer diagnosis and therapies. These conclusions are, of course, tentative. There is a need for much more detailed research based on other aspects and factors for detecting stable technological trajectories that can foster the technology transfer of new sensor in cancer research for improving diagnosis and therapeutics, reducing, whenever possible, world-wide mortality of cancer in society.JEL Classification: I10, O30, O31, O32; O33. Doi: 10.28991/HIJ-2022-03-03-010 Full Text: PDF

High potential of technology to face new respiratory viruses: mechanical ventilation devices for effective healthcare to next pandemic emergencies

“…that support the preparedness and resilience of countries to face unknown infectious respiratory diseases and also other diseases, such as COPD, asthma, bronchitis, lung cancer, etc. (cf., [ [89] , [90] , [91] , [92] ]. To put it differently, the preparedness of countries for next pandemic crises should be oriented to strengthen new technologies in health system to cope with future health emergencies, especially when effective drugs to treat patients with acute respiratory illness are missing [ 12 , 63 , 78 , 79 , 86 , 89 , [93] , [94] , [95] , [96] , [97] , [98] , [99] ].…”

Electroencephalography-based parietofrontal connectivity modulated by electroacupuncture for predicting upper limb motor recovery in subacute stroke

“…Biomarkers provide clinicians the means to identify appropriate candidates for rehabilitation, design personalized rehabilitation programs, and set realistic goals and expectations for both patients and their families. [3,4] Regarding stroke motor prognosis, the proportional recovery rule, which was introduced to forecast motor recovery after stroke, [5] considering that patients with upper extremity motor deficits after stroke tend to recover from 70% to 80% (Prop recovery) at subsequent follow-ups of 3 or 6 months after stroke. [6] However, for some patients with remaining motor impairments, motor recovery was disproportionate and inadequate (Poor recovery).…”

Artificial intelligence assisted diagnoses of fine-needle aspiration of breast diseases: a single-center experience

“…With the application of artificial intelligence (AI) methods, a new horizon opens for FNA and those new technologies can compensate partly for the lack of refined diagnostic methods in developing countries. A plethora of new technologies to improve image classification are available [16][17][18][19][20][21][22][23][24][25]. Image classification methods trained with neural networks make it possible to determine the probability of the classification of a FNA as either a benign or malignant breast disease [10][11][12][13].…”